SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Acorda Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?


To: kenhott who wrote (13)9/24/2008 9:04:36 AM
From: idos  Read Replies (1) | Respond to of 120
 
Strong data from 2 phase III trials and now concerns about the risk of seizure are reduced, I think it is very likely that Fampridine will be approved next year.